Cannabis Suisse Corp.
Cannabis Suisse Corp. (CSUI) Revenue
Annual & quarterly revenue history · segment & region breakdown
CSUI · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsCannabis Suisse Corp. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 25.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2016 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-05-31 | $0.00B | -$0.00B | -25.00% |
| 2024-05-31 | $0.00B | +$0.00B | +200.00% |
| 2023-05-31 | $0.00B | +$0.00B | +28.70% |
| 2022-05-31 | $0.00B | -$0.00B | -84.72% |
| 2021-05-31 | $0.00B | -$0.00B | -79.05% |
| 2020-05-31 | $0.00B | +$0.00B | +3123.63% |
| 2019-05-31 | $0.00B | +$0.00B | +15.85% |
| 2018-05-31 | $0.00B | -$0.00B | -54.20% |
| 2017-05-31 | $0.00B | +$0.00B | — |
| 2016-05-31 | $0.00B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Cannabis Suisse Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Cannabis Suisse Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Cannabis Suisse Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CSUI revenue · 4 questionsCSUI's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 25.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Cannabis Suisse Corp. SEC filings · GAAP · Cannabis Suisse Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026